Sodium Sulfacetamide 10% and Sulfur 2% Cleanser

Manufacturer
Gabar Health Sciences Corp.
Effective date
2024-01-29
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 21:12:10

Label at a glance#

ProductSodium Sulfacetamide 10% and Sulfur 2% Cleanser
Active ingredientSULFACETAMIDE SODIUM, SULFUR
Label structure11 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

DESCRIPTION SECTION

DESCRIPTION:Each gram of sodium sulfacetamide 10% and sulfur 2% cleanser contains 100 mg of sodium sulfacetamide and 20 mg of sulfur in a cleanser containing Aloe Vera leaf Extract, Butylated Hydroxytoluene, Cetyl Alcohol, Citric Acid, Cocamidopropyl Betaine, Disodium EDTA, Glycerin, Glyceryl Stearate SE, PEG-100 Stearate, Phenoxyethanol, Purified Water, Sodium laureth sulfate, Sodium Thiosulfate, Stearyl alcohol, Triacetin, Xanthan Gum.

Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Sodium sulfacetamide is C 8H 9N 2NaO 3S·H 2O with molecular weight of 254.24. Chemically, it is N-[(4-aminophenyl)sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is:

image descriptionimage description

CLINICAL PHARMACOLOGY SECTION

Clinical Pharmacology

Sodium sulfacetamide exerts a bacteriostatic effect against sulfonamide sensitive Gram-positive and Gram-negative microorganisms commonly isolated from secondary cutaneous pyogenic infections. It acts by restricting the synthesis of folic acid required by bacteria for growth, by its competition with para-aminobenzoic acid. There is no clinical data available on the degree and rate of systemic absorption of this product when applied to the skin or scalp. However, significant absorption of sodium sulfacetamide through the skin has been reported.

The following in vitro data is available but the clinical significance is unknown. Organisms that show susceptibility to sodium sulfacetamide are: Streptococci, Staphylococci, E. coli, Klebsiella pneumoniae, Pseudomonas pyocyanea, Salmonella species, Proteus vulgaris, Nocardia and Actinomyces.

The exact mode of action of sulfur in the treatment of acne is unknown, but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.

INDICATIONS & USAGE SECTION

INDICATIONS:

SODIUM SULFACETAMIDE 10% - SULFUR 2% CLEANSER is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

CONTRAINDICATIONS SECTION

CONTRAINDICATIONS:

SODIUM SULFACETAMIDE 10% - SULFUR 2% CLEANSER is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. SODIUM SULFACETAMIDE 10% - SULFUR 2% CLEANSER is not to be used by patients with kidney disease.

WARNINGS SECTION

WARNING

Although it is rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.


FOR EXTERNAL USE ONLY. NOT FOR INTRAVAGINAL OR OPHTHALMIC USE. (KEEP AWAY FROM EYES).


KEEP OUT OF REACH OF CHILDREN.


In case of accidental ingestion contact a poison control center immediately. Keepcontainer tightly closed.

PRECAUTIONS SECTION

Precaution

SPL UNCLASSIFIED SECTION

General:If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the
treatment of acne vulgaris, but patients should be cautioned about the possibility.

SPL UNCLASSIFIED SECTION

Information for Patients:Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician.

SPL UNCLASSIFIED SECTION

Carcinogenesis, Mutagenesis and Impairment of Fertility:Long-term studies in animals have not been performed to evaluate carcinogenic potential.

SPL UNCLASSIFIED SECTION

Pregnancy:Category C. Animal reproduction studies have not been conducted with Sodium Sulfacetamide 10% & Sulfur 2% Cleanser. It is also not known whether Sodium Sulfacetamide 10% & Sulfur 2% Cleanser can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium Sulfacetamide 10% & Sulfur 2% Cleanser should be given to a pregnant woman only if clearly needed.

SPL UNCLASSIFIED SECTION

Nursing Mothers:It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of Sodium  Sulfacetamide 10% & Sulfur 2% Cleanser. However, small amounts of orally administered sulfonamides have milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when Sodium Sulfacetamide 10% & Sulfur 2% Cleanser is administered to a nursing woman.

SPL UNCLASSIFIED SECTION

Pediatric Use:Safety and effectiveness in children under the age of 12 have not been established.

ADVERSE REACTIONS SECTION

Adverse Reaction

Although rare, sodium sulfacetamide may cause local irritation.

Call your doctor for medical advice about side effects.

To report a serious adverse event or obtain product information, call 1-470-737-9424.

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION

Wash affected area once or twice daily, or as directed by your physician. Avoid contact with eyes or mucous membranes. Wet skin and liberally apply to areas to be cleansed, massage gently into skin for 10-20 seconds working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing cleanser off sooner or using less often.

See label booklet for Full Prescribing Information.

HOW SUPPLIED SECTION

HOW SUPPLIED

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.


NOTICE: Protect from freezing and excessive heat. The product may tend to darken slightly on storage. Slight discoloration does not impair the efficacy or safety of the product. Keep bottle tightly closed. Occasionally, a slight discoloration of fabric may occur when an excessive amount of the product is used and comes in contact with white fabrics. This discoloration, however, presents no problem, as it is readily  removed by ordinary laundering without bleaches.


This bottle is not filled to the top but does contain 8 fl oz of product as identified on the front panel of the bottle.

SPL UNCLASSIFIED SECTION

Manufactured for and distributed by:
Gabar Health Sciences Corp.
1 Hartsfield Center Parkway
Atlanta, GA 30354

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82429-108SODIUM SULFACETAMIDE 10% AND SULFUR 2% CLEANSER (SODIUM SULFACETAMIDE, SULFUR) LIQUID [GABAR HEALTH SCIENCES CORP.]2Unmatched20240131_d5df070f-93b5-4792-848d-9c453eb5d857.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
82429-108-08GM - Gram82429-10804a4e04e-88e3-4cfc-bca5-dd3d7d8a8b1512024-01-04

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82429-10882429-108-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4c2e0b7e-4d9e-6594-e063-6294a90a7116d5df070f-93b5-4792-848d-9c453eb5d8572026-03-04Warnings, Adverse reactionsExact identifier
spl set id: d5df070f-93b5-4792-848d-9c453eb5d857

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.